[go: up one dir, main page]

CN110693935A - Garcinia entrapped transdermal patch containing compound obtained by fermenting traditional Chinese medicine starch and fatty oleic acid and self-adhesive matrix and preparation method thereof - Google Patents

Garcinia entrapped transdermal patch containing compound obtained by fermenting traditional Chinese medicine starch and fatty oleic acid and self-adhesive matrix and preparation method thereof Download PDF

Info

Publication number
CN110693935A
CN110693935A CN201911041900.XA CN201911041900A CN110693935A CN 110693935 A CN110693935 A CN 110693935A CN 201911041900 A CN201911041900 A CN 201911041900A CN 110693935 A CN110693935 A CN 110693935A
Authority
CN
China
Prior art keywords
chinese medicine
starch
oleic acid
self
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201911041900.XA
Other languages
Chinese (zh)
Inventor
吕邵娃
李永吉
王艳宏
郭玉岩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heilongjiang University of Chinese Medicine
Original Assignee
Heilongjiang University of Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heilongjiang University of Chinese Medicine filed Critical Heilongjiang University of Chinese Medicine
Priority to CN201911041900.XA priority Critical patent/CN110693935A/en
Publication of CN110693935A publication Critical patent/CN110693935A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/38Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)

Abstract

本发明涉及一包载藤黄的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质的经皮贴剂及制法,所述的载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质是由中药淀粉、中药种子所含的脂肪油酸、液体溶媒和干酵母等自然发酵而成。本发明采用具有低熔点自粘性质的油水两亲的基质包载藤黄,该贴剂具有药物透皮性能优、粘附性能良好、载药量高、透气性好、从皮肤剥离无残留等优势。本发明中包载藤黄的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质透皮贴剂的制备工艺简捷、无环境污染和有机物残留,具有药物分散性好、稳定性好、无皮肤刺激性、生产效率高、成本低廉等特点。

Figure 201911041900

The invention relates to a transdermal patch containing Garcinia cambogia containing a self-adhesive matrix obtained by fermentation of traditional Chinese medicine starch and fatty oleic acid, and a preparation method thereof. The drug-loaded compound containing traditional Chinese medicine starch and fatty oleic acid fermented The self-adhesive matrix is naturally fermented by traditional Chinese medicine starch, fatty oleic acid contained in Chinese medicine seeds, liquid solvent and dry yeast. The invention adopts the oil-water amphiphilic matrix with low melting point and self-adhesive property to encapsulate Garcinia cambogia, and the patch has excellent drug penetration performance, good adhesion performance, high drug loading capacity, good air permeability, no residue after peeling from the skin, etc. Advantage. The preparation process of the self-adhesive matrix transdermal patch containing Garcinia cambogia containing the compound obtained by fermentation of traditional Chinese medicine starch and fatty oleic acid is simple, free of environmental pollution and organic residue, and has the advantages of good drug dispersibility, good stability, and no It has the characteristics of skin irritation, high production efficiency and low cost.

Figure 201911041900

Description

包载藤黄的含中药淀粉和脂肪油酸发酵所得复合物自粘性基 质的经皮贴剂及制法Self-adhesive base of compound containing Chinese medicinal starch and fatty oleic acid fermented with Garcinia cambogia Quality transdermal patch and preparation method

技术领域technical field

本发明属于药物领域,具体涉及一包载藤黄的含中药淀粉和脂肪油酸发酵所得复合物自粘性基质的经皮贴剂及制法。The invention belongs to the field of medicine, in particular to a transdermal patch containing a compound self-adhesive matrix obtained by fermentation of traditional Chinese medicine starch and fatty oleic acid containing Garcinia cambogia and a preparation method thereof.

背景技术Background technique

藤黄是一种具有消肿攻毒,祛腐敛疮之功效的常用中药,有小毒,常用于治疗症瘕积聚和肿瘤等疾病,其主要有效成分藤黄酸和新藤黄酸的水溶性和稳定性均较差,临床常用片剂、胶囊剂、口服液、颗粒剂,尤其以硼砂溶液溶解配制的藤黄酸注射剂为主,仍然难以克服稳定性和安全性等问题。外用给药是一种减毒的良好选择,其研发重点是找到一种适宜基质,能够提升其稳定性和分散性。Garcinia cambogia is a commonly used traditional Chinese medicine with the functions of reducing swelling and fighting poison, dispelling rot and astringing sores. The stability and stability are poor. Tablets, capsules, oral liquids, and granules are commonly used in clinical practice, especially the gambogic acid injection prepared by dissolving borax solution. It is still difficult to overcome the problems of stability and safety. Topical administration is a good option for attenuating toxicity, and its R&D focus is on finding a suitable matrix that can improve its stability and dispersibility.

葛根、天花粉、郁金等中药中含有丰富的淀粉,然而现代研究更多注重其中葛根素、挥发油等小分子的研究,淀粉作为药材的主要组成成分却往往在提取小分子之后被丢弃,造成了资源的浪费。与此类似,马钱子、川楝子等种子类中药富含脂肪油酸,可是更加受到关注的是马钱子碱、士的宁等成分,而脂肪油酸类成分也常常被弃去。因此,将中药淀粉和中药脂肪油酸作为外用剂型的基质进行研究和开发,对于中药资源有效利用是具有重要意义的。Traditional Chinese medicines such as pueraria, trichosandra, and turmeric are rich in starch. However, modern research pays more attention to the study of small molecules such as puerarin and volatile oil. Starch, as the main component of medicinal materials, is often discarded after the extraction of small molecules, resulting in waste of resources. Similar to this, seed Chinese medicines such as strychnine and senneem are rich in fatty oleic acid, but more attention is paid to ingredients such as strychnine and strychnine, and fatty oleic acid is often discarded. Therefore, the research and development of traditional Chinese medicine starch and traditional Chinese medicine fatty oleic acid as the matrix of external dosage forms is of great significance for the effective utilization of traditional Chinese medicine resources.

本研究利用中药淀粉中的内部的疏水性基团和外部的亲水性基团,在特殊的工艺条件下,与中药脂肪油酸的疏水基团形成淀粉-脂肪油酸复合物。该复合物是具有一个较大的疏水性空腔和较强的亲水特性,为自粘性两亲性成分,具有更高的离解温度和更高的抗酶解的特性。因此,该复合物可用于制备包载藤黄的透皮贴剂,以期解决上述存在的问题,研究结果显示无论从粘附性、分散性、刺激性和稳定性等多个角度分析,该贴剂均具有良好的成药性。本研究为原始创新,目前尚无类似的研究报道。In this study, the internal hydrophobic groups and the external hydrophilic groups in traditional Chinese medicine starch were used to form starch-fatty oleic acid complexes with the hydrophobic groups of traditional Chinese medicine fatty oleic acid under special process conditions. The complex has a large hydrophobic cavity and strong hydrophilic properties, is a self-adhesive amphiphilic component, and has higher dissociation temperature and higher resistance to enzymatic hydrolysis. Therefore, the compound can be used to prepare a transdermal patch containing Garcinia cambogia in order to solve the above-mentioned problems. The agents all have good druggability. This research is an original innovation, and there is no similar research report so far.

发明内容SUMMARY OF THE INVENTION

本发明的目的是提供一种包载藤黄的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质的经皮贴剂及制法,以克服现有技术存在的缺陷。The purpose of the present invention is to provide a kind of transdermal patch containing the self-adhesive matrix of the compound obtained by fermentation of Chinese medicine starch and fatty oleic acid containing Garcinia cambogia, and its preparation method, so as to overcome the defects of the prior art.

具体的,本发明提供一种载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质,所述基质具有自粘性和两亲性。Specifically, the present invention provides a drug-loaded self-adhesive matrix containing a compound obtained by fermentation of traditional Chinese medicine starch and fatty oleic acid, and the matrix has self-adhesion and amphiphilicity.

所述载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质由如下重量百分比的组分组成:The self-adhesive matrix of the described drug-containing Chinese medicine starch and fatty oleic acid fermentation compound is made up of the following components by weight:

藤黄 1-10%;Garcinia 1-10%;

具有自粘性质两亲性基质 90-99%;Amphiphilic matrix with self-adhesive properties 90-99%;

优选的,所述载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质由如下重量百分比的组分组成:Preferably, the self-adhesive matrix of the drug-loaded compound containing traditional Chinese medicine starch and fatty oleic acid fermentation is made up of the following components by weight:

藤黄 2-6%;Garcinia 2-6%;

具有自粘性两亲性基质 94-98%;Has a self-adhesive amphiphilic matrix 94-98%;

所述载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质,由如下重量份数的组分经发酵制成:The self-adhesive matrix of the described medicine-loaded compound containing traditional Chinese medicine starch and fatty oleic acid fermentation is made by fermentation of the following components by weight:

Figure RE-GDA0002313213320000021
Figure RE-GDA0002313213320000021

Figure RE-GDA0002313213320000031
Figure RE-GDA0002313213320000031

优选的,所述载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质,由如下重量份数的组分经发酵制成:Preferably, the self-adhesive matrix of the drug-loaded compound containing traditional Chinese medicine starch and fatty oleic acid fermentation is made by fermentation of the following components by weight:

Figure RE-GDA0002313213320000032
Figure RE-GDA0002313213320000032

所述基质的熔点为80℃-100℃,常温下为半固体,高温下为液体。The base has a melting point of 80°C-100°C, is semi-solid at normal temperature, and is liquid at high temperature.

所述中药淀粉选自葛根淀粉、天花粉、板蓝根淀粉、郁金淀粉、高良姜淀粉中的一种或多种;Described traditional Chinese medicine starch is selected from one or more in pueraria starch, trichosandra, isatidis starch, turmeric starch, galangal starch;

优选的,所述中药淀粉为葛根淀粉与郁金淀粉,其重量比为:葛根淀粉:郁金淀粉=1:1-1:3Preferably, the traditional Chinese medicine starch is pueraria starch and turmeric starch, and its weight ratio is: kudzu starch: turmeric starch=1:1-1:3

中药淀粉是影响基质初粘力和亲水性的关键组分,提供对皮肤的粘附性,淀粉不溶于水,发酵后糊化溶胀变稠,原型羟基还可与有机酸形成复合物,形成交联的网状结构,增加疏水基团内部空间,使基质具有较高的载药能力,并产生初粘力和剥离强度。Traditional Chinese medicine starch is a key component that affects the initial viscosity and hydrophilicity of the matrix, providing adhesion to the skin. Starch is insoluble in water, gelatinized, swelled and thickened after fermentation, and the prototype hydroxyl group can also form a complex with organic acids to form The cross-linked network structure increases the internal space of the hydrophobic group, so that the matrix has a high drug-carrying capacity, and produces initial adhesion and peel strength.

所述中药脂肪油酸选自苦楝子、苦豆子、楮实子、曼陀罗子、苍耳子、川楝子或马钱子等种类中的一种或多种;川楝子脂肪油酸相比苦楝子脂肪油酸、苦豆子脂肪油酸具有酸值高,成型率好的优点;马钱子脂肪油酸具有酸值高、含油量高等优点,与中药淀粉的相容性好,提供粘附力的同时增加载药量的优点,因此,优选马钱子脂肪油酸和川楝子脂肪油酸联合使用,优选的重量比为:马钱子脂肪油酸:川楝子脂肪油酸=1:1-1:3;Described traditional Chinese medicine fatty oleic acid is selected from one or more in the kinds such as Neem, Sophora japonica, Amur Fructus, Datura Seed, Xanthium Fructus, Chuan Neem or strychnine; Compared with Neem fatty oleic acid and Sophora bean fatty oleic acid, it has the advantages of high acid value and good molding rate; strychnine fatty oleic acid has the advantages of high acid value and high oil content, and has good compatibility with traditional Chinese medicine starch. The advantages of increasing the drug loading while the adhesion force, therefore, it is preferable to use the strychnine fatty oleic acid and the Sichuan neem fatty oleic acid in combination. =1:1-1:3;

中药脂肪油酸的用量为7-15份,优选的为9-12份,若用量过少,基质粘性过大,在用药期间难以揭贴,且藤黄难以释放;若用量过多,则基质粘性不足,制备的透皮贴剂不能与皮肤粘附。The dosage of the traditional Chinese medicine fatty oleic acid is 7-15 parts, preferably 9-12 parts, if the dosage is too small, the matrix viscosity is too large, it is difficult to peel off during the medication, and the garcinia is difficult to release; if the dosage is too much, the matrix The adhesiveness is insufficient, and the prepared transdermal patch cannot adhere to the skin.

所述液体溶媒常温时为低粘度的液体,可降低中药淀粉的内聚强度, 能使中药多糖增稠,提供发酵反应环境,有利于形成交联的网状结构,改善基质的柔软性和初粘性,从而利于涂布。可选用的主要液体溶媒包括蜂蜜、黄酒、米醋、淀粉浆、水等,蜂蜜和水成本低廉,对皮肤刺激性小,因此优选蜂蜜和水作为主要液体溶媒,优选的重量比为:蜂蜜:水=1:0.5-1:1,主要液体溶媒的用量为40-100份,优选60-100份,若主要液体溶媒的用量过少,贴剂粘附性差;若主要液体溶媒的用量过多,基质层的聚合力显著下降,严重影响成型性。The liquid solvent is a low-viscosity liquid at room temperature, which can reduce the cohesive strength of the traditional Chinese medicine starch, thicken the traditional Chinese medicine polysaccharide, provide a fermentation reaction environment, help to form a cross-linked network structure, and improve the softness and initial stage of the matrix. Viscous, which facilitates coating. The main liquid solvents that can be selected include honey, rice wine, rice vinegar, starch slurry, water, etc. The cost of honey and water is low and the skin irritation is small, so honey and water are preferred as the main liquid solvents, and the preferred weight ratio is: honey: water =1:0.5-1:1, the dosage of the main liquid solvent is 40-100 parts, preferably 60-100 parts, if the amount of the main liquid solvent is too small, the adhesiveness of the patch will be poor; The cohesion of the matrix layer is significantly reduced, which seriously affects the formability.

干酵母主要提供基质膨胀度,具有促进中药淀粉和中药脂肪油酸发生化学反应的作用。可选用的所述干酵母的用量为2-5份,优选的为3-4份。若干酵母用量过少,基质的稠度差,不能保证基质的半固体状态;若干酵母用量过多,基质的酸性过强,刺激性强,贴敷时舒适感差。Dry yeast mainly provides the swelling degree of the matrix, and has the effect of promoting the chemical reaction between Chinese medicine starch and Chinese medicine fatty oleic acid. The optional dosage of the dry yeast is 2-5 parts, preferably 3-4 parts. If the amount of some yeast is too small, the consistency of the matrix is poor, and the semi-solid state of the matrix cannot be guaranteed; if the amount of some yeast is too much, the acidity of the matrix is too strong, the irritation is strong, and the comfort when applied is poor.

本发明的再一个目的是提供所述载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质的制备方法,包括如下步骤:Another object of the present invention is to provide the preparation method of the self-adhesive matrix of the described drug-containing Chinese medicine starch and fatty oleic acid fermentation compound, comprising the steps:

(1)将富含淀粉类中药根或根茎提取后,将不溶于60%乙醇的提取物残渣,减压干燥,粉碎,即得中药淀粉;(1) after the starch-rich Chinese medicine roots or rhizomes are extracted, the extract residue insoluble in 60% ethanol is dried under reduced pressure and pulverized to obtain Chinese medicine starch;

(2)将种子类中药干燥,破碎,冷压,获得中药脂肪中药脂肪油酸;(2) drying, crushing, and cold-pressing the seed Chinese medicine to obtain Chinese medicine fat Chinese medicine fatty oleic acid;

(3)将中药淀粉、中药脂肪中药脂肪油酸、液体溶媒和干酵母混合均匀,30℃密闭2-5h,加入藤黄,混合均匀,30℃密闭1-2h,制成含药的基质;该基质具有较低的软化点和涂布温度,粘附性能良好。(3) Mix the traditional Chinese medicine starch, traditional Chinese medicine fat Chinese medicine fatty oleic acid, liquid solvent and dry yeast evenly, seal at 30°C for 2-5 hours, add Garcinia cambogia, mix well, seal at 30°C for 1-2 hours, and prepare a medicine-containing matrix; The substrate has a low softening point and coating temperature with good adhesion properties.

本发明提供的具有自粘性质的两亲性基质制备方法中,不使用有机溶剂,从而可避免产生环境污染,具有节能环保的特点。在制备过程中,通过隔绝空气和发酵反应,促进中药淀粉与脂肪油酸形成复合物,避免相态分离现象的发生。In the method for preparing the amphiphilic substrate with self-adhesive properties provided by the present invention, no organic solvent is used, so that environmental pollution can be avoided, and the method has the characteristics of energy saving and environmental protection. In the preparation process, by isolating the air and the fermentation reaction, the formation of complexes between traditional Chinese medicine starch and fatty oleic acid is promoted to avoid the occurrence of phase separation.

本发明的另一个目的是提供一种包载藤黄的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质的经皮贴剂,其包括背衬层、模块层、载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质层和保护层;所述模块层覆盖在所述载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质层的一侧,由医用胶圈组成,所述保护层覆盖在所述载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质层的另一侧;Another object of the present invention is to provide a transdermal patch containing a self-adhesive matrix of Garcinia cambogia containing a compound obtained by fermentation of traditional Chinese medicine and fatty oleic acid, which comprises a backing layer, a module layer, a drug-loaded traditional Chinese medicine-containing patch The self-adhesive matrix layer and the protective layer of the compound obtained from the fermentation of starch and fatty oleic acid; the module layer is covered on one side of the self-adhesive matrix layer of the drug-loaded compound containing traditional Chinese medicine starch and fatty oleic acid fermentation, and is composed of A medical rubber ring is formed, and the protective layer covers the other side of the self-adhesive matrix layer of the drug-loaded compound containing traditional Chinese medicine starch and fatty oleic acid fermentation;

所述载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质层的材料为上述载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质。The material of the self-adhesive matrix layer of the drug-loaded compound containing traditional Chinese medicine starch and fatty oleic acid fermentation is the self-adhesive matrix of the above-mentioned drug-loaded compound containing traditional Chinese medicine starch and fatty oleic acid fermentation.

本发明还提供了一种包载藤黄的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质的经皮贴剂的制备方法,包括如下步骤:The present invention also provides a kind of preparation method of the transdermal patch containing the self-adhesive matrix of the compound obtained from the fermentation of Chinese medicine starch and fatty oleic acid containing Garcinia cambogia, comprising the following steps:

(1)将富含淀粉类中药根或根茎提取后,将不溶于60%乙醇的提取物残渣,减压干燥,粉碎,即得中药淀粉;(1) after the starch-rich Chinese medicine roots or rhizomes are extracted, the extract residue insoluble in 60% ethanol is dried under reduced pressure and pulverized to obtain Chinese medicine starch;

(2)将种子类中药干燥,破碎,冷压,获得中药脂肪油酸;(2) drying, crushing, and cold pressing the seed Chinese medicine to obtain Chinese medicine fatty oleic acid;

(3)将中药淀粉、中药脂肪油酸、液体溶媒和干酵母混合均匀,30℃密闭2-5h,加入藤黄,混合均匀,30℃密闭1-2h,制成包载藤黄的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质;(3) Mix the traditional Chinese medicine starch, traditional Chinese medicine fatty oleic acid, liquid solvent and dry yeast evenly, seal at 30°C for 2-5 hours, add Garcinia cambogia, mix evenly, seal at 30°C for 1-2 hours, and prepare a traditional Chinese medicine containing Garcinia cambogia The self-adhesive matrix of the complex obtained by fermentation of starch and fatty oleic acid;

(4)将含药的基质加热至70-80℃,趁热,倾入带有背衬层的医用橡胶圈内,减压干燥2-5h,覆盖上保护层,包装,获得包载藤黄的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质的经皮贴剂。(4) Heat the drug-containing substrate to 70-80°C, pour it into a medical rubber ring with a backing layer while it is still hot, dry under reduced pressure for 2-5 hours, cover with a protective layer, and package to obtain a packaged Garcinia Cambogia The transdermal patch containing the self-adhesive matrix of the compound obtained from the fermentation of traditional Chinese medicine starch and fatty oleic acid.

本发明中包载藤黄的经皮贴剂使用时,可将其贴附于患者的患病部位或穴位皮肤上,每天1次,每次1贴,面积以30-60cm2为宜。When the transdermal patch containing Garcinia Cambogia in the present invention is used, it can be attached to the skin of the patient's diseased part or acupuncture points, once a day, one patch each time, and the area is preferably 30-60 cm 2 .

由于藤黄是脂溶性强的化合物,具有毒性且稳定性差,因此,本发明将其制备成透皮给药制剂,使药物在患病部位释放,减轻肝肾负担,安全性好。该贴剂可连续使用7天,稳定延长主药藤黄的释放,具有长期储存的稳定性、优良的皮肤安全性和适宜的粘附性能。Since Garcinia cambogia is a compound with strong fat solubility, toxicity and poor stability, the present invention prepares it into a transdermal administration preparation, so that the drug can be released at the diseased site, thereby reducing the burden on the liver and kidney, and having good safety. The patch can be used continuously for 7 days, stably prolongs the release of the main drug Garcinia Cambogia, has long-term storage stability, excellent skin safety and suitable adhesion properties.

本发明的有益效果The beneficial effects of the present invention

本发明采用具有低熔点自粘性质的油水两亲的基质包载藤黄,该贴剂药物透皮性能优,粘附性能良好,载药量高,透气性好,从皮肤剥离无残留。本发明中包载藤黄的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质透皮贴剂的制备工艺简捷,无环境污染和有机物残留,具有药物分散性好,稳定性好,无皮肤刺激性,生产效率高,成本低廉的特点。The invention adopts the oil-water amphiphilic matrix with low melting point and self-adhesive property to encapsulate Garcinia cambogia, and the patch medicine has excellent transdermal performance, good adhesion performance, high drug loading capacity, good air permeability and no residue when peeled off from the skin. The preparation process of the self-adhesive matrix transdermal patch containing Garcinia cambogia containing the compound obtained by fermentation of traditional Chinese medicine starch and fatty oleic acid in the present invention is simple, free of environmental pollution and organic residue, and has the advantages of good drug dispersibility, good stability, and no Skin irritation, high production efficiency and low cost.

附图说明Description of drawings

图1、图2:藤黄酸累积释放曲线;Figure 1, Figure 2: Cumulative release curve of gambogic acid;

图3:藤黄酸单位面积累计通过量。Figure 3: Cumulative throughput of gambogic acid per unit area.

具体实施方式Detailed ways

实施例1Example 1

具有自粘性质的两亲性基质的制备:Preparation of the amphiphilic matrix with self-adhesive properties:

将新鲜葛根药材根茎或块根洗净、切碎,榨汁,匀浆过滤,静置1-2小时,弃去上清液。将淀粉层重复用60%乙醇洗涤浸泡至上清液无色,将淀粉层水混悬,离心,得到白色的淀粉层,干燥,粉碎,备用;Wash the fresh pueraria rhizomes or tubers, cut into pieces, squeeze the juice, homogenize and filter, let stand for 1-2 hours, and discard the supernatant. The starch layer was repeatedly washed and soaked with 60% ethanol until the supernatant was colorless, the starch layer was suspended in water, centrifuged to obtain a white starch layer, dried, pulverized, and used for later use;

马钱子干燥破碎冷压,获得马钱子脂肪油酸,备用;The strychnine is dried, crushed and cold-pressed to obtain strychnine fatty oleic acid for use;

取葛根淀粉100g、马钱子脂肪油酸14g、蜂蜜380g、水100g、干酵母2g,不停的快速搅拌,混合均匀,30℃密闭2-5h,加入藤黄20g,混合均匀,30℃密闭1-2h至形成均一黄色透明的胶体,即得。Take 100g of pueraria starch, 14g of strychnine fatty oleic acid, 380g of honey, 100g of water, and 2g of dry yeast, keep stirring quickly, mix well, seal at 30°C for 2-5h, add 20g of Garcinia cambogia, mix well, seal at 30°C 1-2h to form a uniform yellow transparent colloid.

经测定,制得的具有自粘性质的两亲性基质的熔点为67℃。The melting point of the prepared amphiphilic matrix with self-adhesive properties was determined to be 67 °C.

实施例2Example 2

具有自粘性质的两亲性基质的制备:Preparation of the amphiphilic matrix with self-adhesive properties:

将姜黄根或根茎提取后,将不溶于60%乙醇的提取物残渣,减压干燥,粉碎,即得姜黄淀粉;After the turmeric root or rhizome is extracted, the extract residue insoluble in 60% ethanol is dried under reduced pressure and pulverized to obtain turmeric starch;

将川楝子干燥,破碎,冷压,获得川楝子脂肪油酸;drying, crushing, and cold-pressing the Fructus Fructus Fructus to obtain Fructus Fructus Fructus;

将100g姜黄淀粉、15g川楝子脂肪油酸、蜂蜜150g和干酵母2g混合均匀,30℃密闭2-5h,加入藤黄20g,混合均匀,30℃密闭1-2h,制成含药的基质,该基质具有较低的软化点和涂布温度,粘附性能良好。Mix 100g turmeric starch, 15g fat oleic acid from Sichuan neem, 150g honey and 2g dry yeast, seal at 30°C for 2-5h, add 20g Garcinia cambogia, mix well, seal at 30°C for 1-2h to make a drug-containing matrix , the substrate has a lower softening point and coating temperature, and good adhesion properties.

经测定,制得的具有自粘性质的两亲性基质的熔点为58℃。The melting point of the prepared amphiphilic matrix with self-adhesive properties was determined to be 58 °C.

实施例3Example 3

中药淀粉和脂肪油酸均不经干酵母发酵的普通基质的制备:Preparation of common substrates in which both traditional Chinese medicine starch and fatty oleic acid are not fermented by dry yeast:

将新鲜葛根药材根茎或块根洗净、切碎,榨汁,匀浆过滤,静置1-2小时, 弃去上清液。将淀粉层重复用60%乙醇洗涤浸泡至上清液无色,将淀粉层水混悬,离心,得到白色的淀粉层,干燥,粉碎,备用;Wash the fresh pueraria rhizomes or tubers, chop them, squeeze the juice, homogenize and filter, let stand for 1-2 hours, and discard the supernatant. The starch layer was repeatedly washed and soaked with 60% ethanol until the supernatant was colorless, the starch layer was suspended in water, centrifuged to obtain a white starch layer, dried, pulverized, and used for later use;

马钱子干燥破碎冷压获得马钱子脂肪油酸,备用;The strychnine is dried, crushed and cold-pressed to obtain the strychnine fatty oleic acid, which is ready for use;

取葛根淀粉100g、马钱子脂肪油酸14g、蜂蜜380g、水100g、不停的快速搅拌,混合均匀,30℃密闭2-5h,加入藤黄20g,混合均匀,30℃密闭1-2h,至形成均一黄色透明的胶体,即得。Take 100g of pueraria starch, 14g of strychnine fatty oleic acid, 380g of honey, 100g of water, keep stirring rapidly, mix well, seal at 30°C for 2-5h, add 20g of Garcinia cambogia, mix well, seal at 30°C for 1-2h, To form a uniform yellow transparent colloid, that is.

实施例4Example 4

中药淀粉发酵基质的制备:Preparation of traditional Chinese medicine starch fermentation substrate:

将新鲜葛根药材根茎或块根洗净、切碎,榨汁,匀浆过滤,静置1-2小时,弃去上清液。将淀粉层重复用60%乙醇洗涤浸泡至上清液无色,将淀粉层水混悬,离心,得到白色的淀粉层,干燥,粉碎,备用;Wash the fresh pueraria rhizomes or tubers, cut into pieces, squeeze the juice, homogenize and filter, let stand for 1-2 hours, and discard the supernatant. The starch layer was repeatedly washed and soaked with 60% ethanol until the supernatant was colorless, the starch layer was suspended in water, and centrifuged to obtain a white starch layer, which was dried, pulverized, and used for later use;

取葛根淀粉100g、蜂蜜380g、水100g、干酵母2g,不停的快速搅拌, 混合均匀,30℃密闭2-5h,加入藤黄20g,混合均匀,30℃密闭1-2h,至形成均一浅黄色透明的胶体,即得。Take 100g of kudzu starch, 380g of honey, 100g of water, and 2g of dry yeast, keep stirring quickly, mix well, seal at 30°C for 2-5h, add 20g of Garcinia cambogia, mix well, seal at 30°C for 1-2h, until a uniform shallow A yellow transparent colloid is obtained.

实施例5Example 5

中药脂肪油酸发酵基质的制备:Preparation of traditional Chinese medicine fatty oleic acid fermentation substrate:

马钱子干燥破碎冷压获得马钱子脂肪油酸,备用;The strychnine is dried, crushed and cold-pressed to obtain the strychnine fatty oleic acid, which is ready for use;

取马钱子脂肪油酸14g、干酵母2g、蜂蜜380g、水100g,不停的快速搅拌,混合均匀,30℃密闭2-5h,加入藤黄20g,混合均匀,30℃密闭 1~2h,即得。Take 14g of strychnine fatty oleic acid, 2g of dry yeast, 380g of honey, and 100g of water, keep stirring quickly, mix evenly, seal at 30°C for 2-5h, add 20g of Garcinia cambogia, mix well, seal at 30°C for 1-2h, That's it.

实施例6Example 6

载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质的制备:Preparation of drug-loaded self-adhesive matrix containing traditional Chinese medicine starch and fatty oleic acid fermentation compound:

将姜黄根或根茎提取后,将不溶于60%乙醇的提取物残渣,减压干燥,粉碎,即得姜黄淀粉;After the turmeric root or rhizome is extracted, the extract residue insoluble in 60% ethanol is dried under reduced pressure and pulverized to obtain turmeric starch;

将川楝子干燥,破碎,冷压,获得川楝子脂肪油酸;drying, crushing, and cold-pressing the Fructus Fructus Fructus to obtain Fructus Fructus Fructus;

将300g姜黄淀粉、45g川楝子脂肪油酸、蜂蜜450g和干酵母6g混合均匀,30℃密闭2-5h,加入藤黄,混合均匀,30℃密闭1-2h,制成含药的基质,即得。Mix 300g turmeric starch, 45g fat oleic acid from senneem, 450g honey and 6g dry yeast, seal at 30°C for 2-5h, add Garcinia cambogia, mix well, seal at 30°C for 1-2h to make a drug-containing matrix, That's it.

实施例7:粘附性能的测定Example 7: Determination of Adhesion Properties

1.初粘力的测定:使用探针法测定贴剂的初粘力。1. Determination of initial adhesive force: The initial adhesive force of the patch was measured by the probe method.

将供试品贴剂揭去保护层,粘贴于洁净的试验板上,测力仪探针以 300mm·min-1的速度下降,与贴膏表面接触3s后离开,记录探针离开贴膏表面时的最大力,连续测定6次,取平均值,实验结果见表1。Remove the protective layer of the test patch, paste it on a clean test board, the dynamometer probe descends at a speed of 300mm·min -1 , and leaves after contacting the surface of the patch for 3s, and records that the probe leaves the patch surface. The maximum force at the time was measured 6 times continuously, and the average value was taken. The experimental results are shown in Table 1.

2.持粘力的测定:将贴剂粘贴于垂直放置的试验板上,用持粘力测定仪测定。2. Determination of sticking force: stick the patch on a test plate placed vertically, and measure it with a sticking force tester.

将供试品贴剂揭去保护层,平行于板的纵向,粘贴在紧挨着的洁净不锈钢试验板和不锈钢加载板中部,用压辊在贴剂上以(300±10)mm/min的速度来回滚压一次,确保粘接处无气泡存在。室温放置20min后将其垂直固定于试验架上,沿贴剂的长度方向悬挂一定质量的砝码,记录贴剂脱落的时间。连续测定6次,取平均值,实验结果见表1。Remove the protective layer of the test patch, parallel to the longitudinal direction of the plate, and paste it on the middle of the adjacent clean stainless steel test plate and stainless steel loading plate. Roll back and forth at a speed to ensure that there are no air bubbles in the bond. After standing at room temperature for 20min, fix it vertically on the test stand, hang a certain mass of weight along the length of the patch, and record the time when the patch falls off. Continuous measurement 6 times, take the average value, the experimental results are shown in Table 1.

3.剥离强度的测定:采用180°剥离试验测定贴剂的剥离强度。3. Determination of peel strength: The peel strength of the patch was measured by a 180° peel test.

将供试品贴剂剪裁为10cm×2cm大小后揭去保护层,贴于洁净的不锈钢板上,末端处将贴剂的粘合剂层与洁净的聚酯薄膜粘接,用压辊在贴剂上以(300±10)mm/min的速度来回滚压一次,确保粘接处无气泡存在。室温放置20-40min,将薄膜和不锈钢板分别上、下夹持于剥离试验机上,以 (300±10)mm/min连续剥离,记录贴剂的剥离强度。连续测定6次,取平均值,实验结果见表1。Cut the test patch to a size of 10cm×2cm, peel off the protective layer, and stick it on a clean stainless steel plate. Adhere the adhesive layer of the patch to the clean polyester film at the end, and use a pressure roller to stick it. Roll back and forth at the speed of (300±10)mm/min on the adhesive to ensure that there are no air bubbles in the bonding place. Place at room temperature for 20-40min, clamp the film and stainless steel plate up and down on the peel tester respectively, peel off continuously at (300±10) mm/min, and record the peel strength of the patch. Continuous measurement 6 times, take the average value, the experimental results are shown in Table 1.

表1各组不同基质粘附性能的试验结果Table 1 Test results of adhesion performance of different substrates in each group

Figure RE-GDA0002313213320000091
Figure RE-GDA0002313213320000091

(注:*代表与中药淀粉和脂肪油酸均未发酵基质比较p<0.05,在初粘力、持粘力、剥离强度有显著(Note: * represents p < 0.05 compared with the unfermented matrix of traditional Chinese medicine starch and fatty oleic acid, and there is a significant difference in initial adhesion, holding force and peel strength.

性差异)sexual differences)

实施例8:体外释放试验Example 8: In vitro release test

采用Franz扩散池法,上室为扩散室,下室为接受室。将制备好的贴剂揭去保护层,模块层朝上、含药物面朝下固定在FranZ扩散池的接收池上,盖上上半池并用铁夹夹紧。接受池中加入已超声脱气的释放介质60%乙醇溶液。扩散面积为3.14cm2,接受体积为7ml,搅拌速度为250r/min,接受液的温度控制在(32±0.5)℃。分别于实验开始后的1h、2h、4h、6h、8h、10h、12h、14h、24h、48h、72h、96h、120h、144h和168h取出释放介质5ml(同时补充同温等量新鲜释放介质),直接进样测定代表成分藤黄酸的含量,计算累积释放率Q%。每组实验平行3次。藤黄酸累积释放率Q%见图1和图2。Franz diffusion cell method was used, the upper chamber was the diffusion chamber, and the lower chamber was the receiving chamber. Remove the protective layer of the prepared patch, fix the module layer up and the drug-containing side down on the receiving cell of the FranZ diffusion cell, cover the upper half cell and clamp it with iron clips. Ultrasonic degassed release medium 60% ethanol solution was added to the receiving cell. The diffusion area was 3.14 cm 2 , the receiving volume was 7 ml, the stirring speed was 250 r/min, and the temperature of the receiving liquid was controlled at (32±0.5) ℃. 1h, 2h, 4h, 6h, 8h, 10h, 12h, 14h, 24h, 48h, 72h, 96h, 120h, 144h and 168h after the start of the experiment, take out 5ml of the release medium (and supplement the same amount of fresh release medium at the same temperature) , directly inject the sample to determine the content of the representative component gambogic acid, and calculate the cumulative release rate Q%. Each group of experiments was performed in parallel 3 times. The cumulative release rate Q% of gambogic acid is shown in Figures 1 and 2.

实施例9:体外透皮试验Example 9: In vitro skin penetration test

取体重(18±2)g健康裸鼠,饲养24h,用生理盐水洗净皮肤表面,断颈处死,剥离无损伤皮肤,小心刮去皮下组织及脂肪,用生理盐水洗净, -20℃冰箱保存备用。实验时取出备好的皮肤,自然解冻后用生理盐水浸洗数遍,将皮肤固定在扩散池上,角质层朝上,用30%乙醇-生理盐水为接受液。池内置磁力搅拌子,转速为300r/min,扩散池面积为2cm2,接受池的总体积为7ml,恒温(37±1)℃水浴,先平衡30min,更换接收液,排尽皮肤下的空气,纱布吸干皮肤表面的液体。将制备好的贴剂除去保护层,精密刮取2g含药基质,紧密敷贴在裸鼠皮上。于24h、48h、 72h、96h、120h、144h、168h分别从接受池内取样1ml,并补充等温度同体积的接受液。样品经0.45μm微孔滤膜滤过,取续滤液,HPLC测定样品中藤黄酸的含量,计算出各时间点单位面积的累计透过量(μ g/cm2)重复实验3次,以平均值为实验结果,实验结果见表2、图3。Healthy nude mice with a body weight of (18±2) g were taken, reared for 24 hours, the skin surface was washed with normal saline, sacrificed by severed neck, the skin without damage was peeled off, the subcutaneous tissue and fat were carefully scraped off, washed with normal saline, and kept in a -20°C refrigerator. Save for backup. During the experiment, the prepared skin was taken out, thawed naturally and washed several times with physiological saline, and the skin was fixed on the diffusion cell with the stratum corneum facing upward, and 30% ethanol-physiological saline was used as the receiving solution. The cell has a built-in magnetic stirrer, the rotating speed is 300r/min, the area of the diffusion cell is 2cm 2 , the total volume of the receiving cell is 7ml, the constant temperature (37±1) ℃ water bath, first equilibrate for 30min, replace the receiving liquid, and exhaust the air under the skin , the gauze absorbs the liquid on the surface of the skin. Remove the protective layer from the prepared patch, precisely scrape 2 g of the drug-containing matrix, and stick it tightly on the skin of the nude mice. At 24h, 48h, 72h, 96h, 120h, 144h, and 168h, 1ml was sampled from the receiving pool respectively, and the receiving solution of the same temperature and volume was supplemented. The sample was filtered through a 0.45 μm microporous membrane, and the subsequent filtrate was taken. The content of gambogic acid in the sample was determined by HPLC, and the cumulative permeation per unit area (μg/cm 2 ) at each time point was calculated. Repeat the experiment 3 times, with the average The values are the experimental results, and the experimental results are shown in Table 2 and Figure 3.

表2载药藤黄酸的不同基质贴剂体外透皮试验的结果Table 2 Results of in vitro transdermal tests of different matrix patches loaded with gambogic acid

Figure RE-GDA0002313213320000101
Figure RE-GDA0002313213320000101

(注:*代表与中药淀粉和脂肪油酸均未发酵基质比较p<0.05,24h、48h、72h、96h、120h、144h、 168h时单位面积累计透过量与中药淀粉和脂肪油酸均未发酵基质相比有显著性差异)(Note: * means p < 0.05 compared with the unfermented substrates of traditional Chinese medicine starch and fatty oleic acid, and the cumulative permeation amount per unit area at 24h, 48h, 72h, 96h, 120h, 144h, and 168h is comparable to that of unfermented traditional Chinese medicine starch and fatty oleic acid. There is a significant difference compared to the matrix)

实施例10:稳定性试验Example 10: Stability test

1.试验方法:将实施例1-6中包载藤黄的透皮贴剂在室温下储存3个月后,目测观察外观是否有结晶析出。1. Test method: After storing the transdermal patch containing Garcinia Cambogia in Example 1-6 at room temperature for 3 months, visually observe whether there is crystal precipitation on the appearance.

2.试验结果:实施例1-6的贴剂经观察,实施例3有结晶形成,其他组无结晶形成,说明发酵过程使贴剂稳定性增强。2. Test results: The patches of Examples 1-6 were observed to form crystals in Example 3, but no crystals were formed in other groups, indicating that the fermentation process enhanced the stability of the patches.

实施例11:皮肤刺激性试验Example 11: Skin irritation test

1.试验方法:取2.8-3.0kg健康家兔6只,平均分为完整皮肤组和破损皮肤组,于给药前24h将动物背部脱毛。分别将受试药物(实施例1-2、4-6 的贴剂,10cm2)和对照药物(实施例3的贴剂,10cm2)各5片分别贴于动物背部的受试药物区和对照药物区(50cm2),每日敷贴1次,连续7天。于末次给药后24h用温水和生理盐水去除残留物,观察去除受试药物1h、24h、 48h和72h敷贴部位的红斑和水肿情况以及上述变化的恢复情况和时间, 对每只动物试验结果进行刺激反应评分及刺激强度评价。1. Test method: 6 healthy rabbits of 2.8-3.0 kg were taken and equally divided into intact skin group and damaged skin group, and the back of the animals was depilated 24h before administration. Five pieces of the test drug (patches of Examples 1-2, 4-6, 10cm 2 ) and control drugs (patches of Example 3, 10cm 2 ) were respectively affixed to the test drug area and the back of the animal. The control drug area (50cm 2 ) was applied once a day for 7 consecutive days. 24h after the last administration, the residues were removed with warm water and normal saline, and the erythema and edema at the application site of the test drug at 1h, 24h, 48h and 72h, as well as the recovery and time of the above changes were observed. Stimulus response scores and stimulus intensity evaluations were performed.

2.试验结果:实施例1-2、4-6的贴剂经家兔皮肤刺激试验,完整皮肤组及破损皮肤组给药均未见刺激反应,实施例3造成敷贴部位的轻微红斑和水肿。2. test result: the patch of embodiment 1-2, 4-6 is through rabbit skin irritation test, intact skin group and damaged skin group administration all have no irritation reaction, embodiment 3 causes the slight erythema of the application site and Edema.

实施例12:皮肤过敏试验Example 12: Skin Allergy Test

1.试验方法:取250g-300g健康豚鼠30只,平均分为三组,每组10只, 雌雄各半。给药前24h将豚鼠背部左侧(致敏)或右侧(激发)毛脱掉,去毛范围每侧约4×4cm。第1组贴受试药物(实施例1-2、4-6的贴剂,10cm2), 第2组贴阴性对照药物(实施例3的贴剂,10cm2),第3组每侧贴阳性致敏物,2,4一二硝氯苯的1%乙醇溶液0.2ml。1. Test method: Take 30 healthy guinea pigs of 250g-300g and divide them into three groups on average, 10 in each group, half male and half male. The left (sensitized) or right (excited) back of the guinea pigs was shaved 24 hours before administration, and the hair removal area was about 4×4 cm on each side. The test drug (the patch of Example 1-2, 4-6, 10cm 2 ) was attached to the first group, the negative control drug (the patch of Example 3, 10 cm 2 ) was attached to the second group, and the third group was attached to each side Positive sensitizer, 0.2ml of 1% ethanol solution of 2,4-dinitrochlorobenzene.

致敏:取受试药物(实施例1-2、4-6的贴剂,10cm2)贴于动物左侧脱毛区外层,用橡皮膏固定,持续6h后去除受试药物。第7天和第14天以同样方法各重复一次。阴性对照组(实施例3)和阳性对照组(2,4一二硝氯苯) 方法均同受试药物组。Sensitization: Take the test drug (patches of Examples 1-2, 4-6, 10cm 2 ) and stick it on the outer layer of the left depilation area of the animal, fix it with an adhesive plaster, and remove the test drug after 6 hours. The same method was repeated on days 7 and 14. The methods of the negative control group (Example 3) and the positive control group (2,4-dinitrochlorobenzene) were the same as the test drug group.

激发:于末次致敏后14天,将受试药物贴于动物右侧脱毛区外层,用橡皮膏固定,持续6h后去除受试药物,即刻观察,然后于24h、48h、72h再次观察皮肤过敏反应情况。阴性对照组(实施例3)和阳性对照组(2,4一二硝氯苯)方法均同受试药物组。Challenge: 14 days after the last sensitization, the test drug was applied to the outer layer of the hair removal area on the right side of the animal, fixed with an adhesive plaster, and the test drug was removed after 6 hours, and observed immediately, and then the skin was observed again at 24h, 48h, and 72h Allergic reaction. The methods of the negative control group (Example 3) and the positive control group (2,4-dinitrochlorobenzene) were the same as those of the tested drug group.

对每只动物试验结果进行过敏反应评分及过敏强度评价。Allergic reaction scores and allergic intensity evaluations were performed on the test results of each animal.

2.试验结果:实施例1-6的贴剂经豚鼠皮肤过敏试验,未见明显过敏反应。2. Test results: The patches of Examples 1-6 were tested by guinea pig skin allergy test, and no obvious allergic reaction was found.

以上描述了本发明优选实施方式,然其并非用以限定本发明。本领域技术人员对在此公开的实施方案可进行并不偏离本发明范畴和精神的改进和变化。The preferred embodiments of the present invention have been described above, but are not intended to limit the present invention. Modifications and variations of the embodiments disclosed herein may be made by those skilled in the art without departing from the scope and spirit of the invention.

Claims (10)

1.一种载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质,其特征在于,由如下重量百分比的组分组成:1. a drug-loaded self-adhesive matrix containing traditional Chinese medicine starch and fatty oleic acid fermentation gained compound, is characterized in that, is made up of the component of following weight percent: 藤黄1-10%;Garcinia 1-10%; 含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质90-99%。90-99% of the self-adhesive matrix containing the compound obtained by fermentation of traditional Chinese medicine starch and fatty oleic acid. 2.根据权利要求1所述载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质,其特征在于,由如下重量百分比的组分组成:2. the self-adhesive matrix containing traditional Chinese medicine starch and fatty oleic acid fermentation gained compound of drug loading according to claim 1, is characterized in that, is made up of the component of following weight percent: 藤黄2-6%;Garcinia 2-6%; 含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质94-98%。Self-adhesive matrix containing 94-98% of the compound obtained by fermentation of traditional Chinese medicine starch and fatty oleic acid. 3.根据权利要求1或2所述载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质,其特征在于,所述含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质,由如下重量份数的组分经发酵制成:3. according to the self-adhesive matrix of the compound that contains Chinese medicine starch and fatty oleic acid fermentation gained according to claim 1 and 2, it is characterized in that, the described self-adhesive matrix that contains Chinese medicine starch and the compound obtained by fermentation of fatty oleic acid , is made through fermentation by the component of following parts by weight:
Figure RE-FDA0002313213310000011
Figure RE-FDA0002313213310000011
4.根据权利要求3所述载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质,其特征在于,所述含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质,由如下重量份数的组分经发酵组成:4. the self-adhesive matrix containing the compound obtained from the fermentation of traditional Chinese medicine starch and fatty oleic acid according to claim 3, is characterized in that, the described self-adhesive matrix containing the compound obtained from the fermentation of traditional Chinese medicine starch and fatty oleic acid is composed of The components of following parts by weight are formed through fermentation:
Figure RE-FDA0002313213310000012
Figure RE-FDA0002313213310000012
5.根据权利要求3所述载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质,其特征在于,所述载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质具有自粘性油水两亲性,所述基质的熔点为80℃-100℃,常温下为半固体,高温下为液体。5. according to the self-adhesive matrix of the compound obtained by the fermentation of Chinese medicine starch and fatty oleic acid of the medicine-carrying according to claim 3, it is characterized in that, the self-adhesion of the compound of the compound obtained by the fermentation of Chinese medicine starch and fatty oleic acid of the medicine-carrying The matrix has self-adhesive oil-water amphiphilicity, the melting point of the matrix is 80°C-100°C, and it is semi-solid at normal temperature and liquid at high temperature. 6.根据权利要求3所述载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质,其特征在于,所述中药淀粉选自葛根淀粉、天花粉、板蓝根淀粉、郁金淀粉、高良姜淀粉中的一种或多种;6. the self-adhesive matrix containing traditional Chinese medicine starch and fatty oleic acid fermentation gained compound according to claim 3, it is characterized in that, described traditional Chinese medicine starch is selected from Pueraria lobata starch, Trichosanthes, Radix Isatidis starch, curcuma starch, Gao Liang One or more of ginger starch; 所述中药脂肪油酸选自苦楝子、苦豆子、楮实子、曼陀罗子、苍耳子、川楝子或马钱子中的一种或多种;Described traditional Chinese medicine fatty oleic acid is selected from one or more in Neem, Sophora japonica, Amur Fructus, Datura, Xanthium, Chuan Neem or Strychni; 所述液体溶媒选自蜂蜜、黄酒、米醋、淀粉浆、水中的一种或多种。The liquid solvent is selected from one or more of honey, rice wine, rice vinegar, starch slurry and water. 7.根据权利要求6所述载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质,其特征在于,所述中药淀粉为葛根淀粉与郁金淀粉,其重量比为:葛根淀粉:郁金淀粉=1:1-1:3;所述中药脂肪油酸为马钱子与川楝子,其重量比为:马钱子:川楝子=1:0.5-1:1;所述液体溶媒为蜂蜜和水,重量比为:蜂蜜:水=1:0.5-1:1。7. the self-adhesive matrix containing traditional Chinese medicine starch and fatty oleic acid fermentation gained compound of drug-carrying according to claim 6, is characterized in that, described Chinese medicine starch is pueraria starch and Radix curcumae, and its weight ratio is: pueraria starch : Turmeric starch=1:1-1:3; Described traditional Chinese medicine fatty oleic acid is strychnine and Fructus Fructus, and its weight ratio is: Fructus Fructus: Fructus Fructus=1:0.5-1:1; The liquid solvent is honey and water, and the weight ratio is: honey: water=1:0.5-1:1. 8.根据权利要求7所述载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质,其特征在于,中药淀粉和脂肪油酸的质量比为2:1-3:1。8. the self-adhesive matrix containing the compound obtained from the fermentation of traditional Chinese medicine starch and fatty oleic acid for carrying medicine according to claim 7, is characterized in that, the mass ratio of traditional Chinese medicine starch and fatty oleic acid is 2:1-3:1. 9.一种包载藤黄的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质的经皮贴剂,其特征在于,包括背衬层、模块层、载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质层和保护层;所述模块层覆盖在所述载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质层的一侧,由医用胶圈组成,所述保护层覆盖在所述载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质层的另一侧;9. A transdermal patch containing the self-adhesive matrix of Chinese medicine starch and fatty oleic acid fermentation gained compound containing Garcinia cambogia, is characterized in that, comprises backing layer, module layer, medicine-loaded containing Chinese medicine starch and fat A self-adhesive matrix layer and a protective layer of the compound obtained by oleic acid fermentation; the module layer is covered on one side of the self-adhesive matrix layer of the drug-loaded compound containing traditional Chinese medicine starch and fatty oleic acid fermentation, and is formed by a medical rubber ring. composition, the protective layer covers the other side of the self-adhesive matrix layer of the drug-loaded compound containing traditional Chinese medicine starch and fatty oleic acid fermentation; 所述载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质层的材料为权利要求1-8任一项所述载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质。The material of the self-adhesive matrix layer of the drug-loaded compound containing traditional Chinese medicine starch and fatty oleic acid fermentation is the self-adhesive matrix layer of the drug-loaded compound containing traditional Chinese medicine starch and fatty oleic acid fermentation according to any one of claims 1-8. sticky base. 10.制备权利要求9所述的包载藤黄的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质经皮贴剂的方法,其特征在于,包括如下步骤:10. the method for preparing the self-adhesive matrix transdermal patch of the compound containing Chinese medicine starch and fatty oleic acid fermentation gained compound containing Garcinia Cambogia as claimed in claim 9, is characterized in that, comprises the steps: (1)将富含淀粉类中药根或根茎提取后,将不溶于60%乙醇的提取物残渣,减压干燥,粉碎,即得中药淀粉;(1) after the starch-rich Chinese medicine roots or rhizomes are extracted, the extract residue insoluble in 60% ethanol is dried under reduced pressure and pulverized to obtain Chinese medicine starch; (2)将种子类中药干燥,破碎,冷压,获得中药脂肪油酸;(2) drying, crushing, and cold pressing the seed Chinese medicine to obtain Chinese medicine fatty oleic acid; (3)将中药淀粉、中药脂肪油酸、液体溶媒和干酵母混合均匀,30℃密闭2-5h,加入藤黄,混合均匀,30℃密闭1-2h,制成包载藤黄的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质;(3) Mix the traditional Chinese medicine starch, traditional Chinese medicine fatty oleic acid, liquid solvent and dry yeast evenly, seal at 30°C for 2-5 hours, add Garcinia cambogia, mix evenly, seal at 30°C for 1-2 hours, and prepare a traditional Chinese medicine containing Garcinia cambogia The self-adhesive matrix of the complex obtained by fermentation of starch and fatty oleic acid; (4)将载药的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质加热至70-80℃,趁热,倾入带有背衬层的医用橡胶圈内,减压干燥2-5h,覆盖上保护层,包装,获得包载藤黄的含中药淀粉和脂肪油酸发酵所得复合物的自粘性基质的经皮贴剂。(4) heating the drug-loaded self-adhesive matrix of the compound obtained by fermentation of traditional Chinese medicine starch and fatty oleic acid to 70-80 ° C, pouring it into a medical rubber ring with a backing layer while it is still hot, and drying under reduced pressure for 2- 5h, covered with a protective layer and packaged to obtain a transdermal patch containing a self-adhesive matrix of Garcinia cambogia containing a compound obtained by fermentation of traditional Chinese medicine starch and fatty oleic acid.
CN201911041900.XA 2019-10-30 2019-10-30 Garcinia entrapped transdermal patch containing compound obtained by fermenting traditional Chinese medicine starch and fatty oleic acid and self-adhesive matrix and preparation method thereof Pending CN110693935A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911041900.XA CN110693935A (en) 2019-10-30 2019-10-30 Garcinia entrapped transdermal patch containing compound obtained by fermenting traditional Chinese medicine starch and fatty oleic acid and self-adhesive matrix and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911041900.XA CN110693935A (en) 2019-10-30 2019-10-30 Garcinia entrapped transdermal patch containing compound obtained by fermenting traditional Chinese medicine starch and fatty oleic acid and self-adhesive matrix and preparation method thereof

Publications (1)

Publication Number Publication Date
CN110693935A true CN110693935A (en) 2020-01-17

Family

ID=69203836

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911041900.XA Pending CN110693935A (en) 2019-10-30 2019-10-30 Garcinia entrapped transdermal patch containing compound obtained by fermenting traditional Chinese medicine starch and fatty oleic acid and self-adhesive matrix and preparation method thereof

Country Status (1)

Country Link
CN (1) CN110693935A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1473056A (en) * 2000-10-02 2004-02-04 ����Ī�����ɷ����޹�˾ Self-adhesive wound dressing
CN102772417A (en) * 2012-07-24 2012-11-14 上海现代药物制剂工程研究中心有限公司 Period effect percutaneous patch of self viscosity elastic body substrate containing testosterone and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1473056A (en) * 2000-10-02 2004-02-04 ����Ī�����ɷ����޹�˾ Self-adhesive wound dressing
CN102772417A (en) * 2012-07-24 2012-11-14 上海现代药物制剂工程研究中心有限公司 Period effect percutaneous patch of self viscosity elastic body substrate containing testosterone and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
马建芳等: "透皮给药系统热熔压敏胶基质处方的优化与初步应用", 《中国医药工业杂志》 *

Similar Documents

Publication Publication Date Title
CN101947322B (en) Gel patch matrix and preparation method and application thereof
JP2007502269A (en) Temperature-sensitive state change hydrogel composition and method for producing the same
CN104274859B (en) A kind of hydrocolloid containing Radix Notoginseng total arasaponins is applied ointment or plaster and preparation method thereof
CN103356723A (en) Cooling paste for children and preparation method thereof
CN102772590A (en) Traditional Chinese medicine composition, gel paste and preparation method
CN1262299C (en) Chinese medicine adhesive film for preventing and treating coronary heart disease and angina pectoris and its preparing method
CN1647803A (en) Chinese medicine composition plaster for external anti-inflammation and analgetics
CN110693935A (en) Garcinia entrapped transdermal patch containing compound obtained by fermenting traditional Chinese medicine starch and fatty oleic acid and self-adhesive matrix and preparation method thereof
CN114699439B (en) A self-heating gel patch with anti-inflammatory effect and its preparation method
CN105125984B (en) A kind of aqueous Chinese medicine plaster for external application for treating infantile cough
CN101618030B (en) Triptolide transdermal patch and preparation method thereof
CN100544730C (en) Magnesium isoglycyrrhetate external preparation and its production and application
CN103316082A (en) Jiufen cataplasm and preparation method thereof
CN1306842A (en) Preparation of shaolin plaster for rheumatism and wound
CN1806823B (en) Externally applied wind-expelling Chinese medicinal composition plaster
CN108210484B (en) Tamoxifen gel patch and preparation method thereof
CN103705937A (en) Medicinal plaster substrate, medicinal plaster using the substrate and preparation method thereof
CN108379461A (en) A kind of graphene blood pressure lowering patch and preparation method thereof
CN102397443A (en) Stasis-dissipating pain-relieving cataplasm for treating hyperplasia of mammary glands and preparation method thereof
CN108653244A (en) A kind of graphene male helps member patch and preparation method thereof
CN102940754B (en) Rhizoma cyperi four-drug decoction transdermal patch and preparation method thereof
CN113768905A (en) Corydalis total alkaloid transdermal preparation and preparation method thereof
CN101422427B (en) Magnesium isoglycyrrhizinate cream and preparation method and use thereof
CN105797100A (en) Pressure-sensitive adhesive patch with blood activating and pain arresting functions and preparation method thereof
CN111297798A (en) Tripterine microemulsion gel and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200117

WD01 Invention patent application deemed withdrawn after publication